Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -20.05x is 16% below its 5-year average of -17.28x, near the high end of its 5-year range (-264.60x–-7.84x).
As of the fiscal period ended Sunday, June 30, 2024. 75.47% above its 12-month average of -81.73x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2024 (2024-06-30): -20.05x.
INTEREST COVERAGE RATIO
-20.05x
INTEREST COVERAGE RATIO AVG TTM
-81.73x
INTEREST COVERAGE RATIO AVG 3Y
-47.87x
INTEREST COVERAGE RATIO AVG 5Y
-17.28x
INTEREST COVERAGE RATIO AVG 10Y
-11.12x
INTEREST COVERAGE RATIO AVG 15Y
-12.17x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+75.47%
CURRENT VS 3Y AVG
+58.12%
CURRENT VS 5Y AVG
-16.02%
CURRENT VS 10Y AVG
-80.28%
CURRENT VS 15Y AVG
-64.73%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-211.29%
vs the sector median at left
Talphera, Inc.
Market Cap
$57.61M
Interest Coverage Ratio
-20.05x
TTM Avg
-81.73x
3Y Avg
-47.87x
5Y Avg
-17.28x
Market Cap
$57.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$57.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.29M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.43M
Interest Coverage Ratio
-3392.06x
TTM Avg
18.65x
3Y Avg
15.79x
5Y Avg
19.13x
Market Cap
$58.44M
Interest Coverage Ratio
-5.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$56.02M
Interest Coverage Ratio
-17.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Talphera, Inc. (TLPH) | $57.61M | -20.05x | -81.73x | -47.87x | -17.28x |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | N/A | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | N/A | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | N/A | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | -3392.06x | 18.65x | 15.79x | 19.13x |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | -5.91x | N/A | N/A | N/A |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | N/A | N/A | N/A | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | -17.93x | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $55.25M | -18.51x | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | N/A | N/A | N/A | N/A |
Interest Coverage
-20.0x
Debt/Equity
0.00
Current Ratio
4.29
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-06-30 | -20.05x |
| 2024-03-31 | -23.41x |
| 2023-12-31 | -18.87x |
| 2023-06-30 | -264.60x |
| 2023-03-31 | -44.77x |
| 2022-12-31 | -39.08x |
| 2022-09-30 | -18.46x |
| 2021-12-31 | -17.51x |
| 2021-09-30 | -16.05x |
| 2021-06-30 | -15.90x |
| 2021-03-31 | -13.60x |
| 2020-09-30 | -10.97x |
| 2020-06-30 | -7.84x |
| 2020-03-31 | -17.23x |
| 2019-12-31 | -18.04x |
| 2019-06-30 | -26.72x |
| 2019-03-31 | -6.21x |
| 2018-12-31 | -3.54x |
| 2018-09-30 | -2.71x |
| 2018-06-30 | -2.00x |
| 2018-03-31 | -2.39x |
| 2017-12-31 | -0.68x |
| 2017-09-30 | -2.40x |
| 2017-06-30 | -2.83x |
| 2017-03-31 | -3.62x |
| 2016-12-31 | -0.71x |
| 2016-09-30 | -2.57x |
| 2016-06-30 | -12.11x |
| 2016-03-31 | -12.53x |
| 2015-12-31 | -2.67x |
| 2015-09-30 | 9.96x |
| 2015-06-30 | -10.45x |
| 2015-03-31 | -13.21x |
| 2014-12-31 | -14.35x |
| 2014-09-30 | -6.21x |
| 2014-06-30 | -23.13x |
| 2014-03-31 | -18.10x |
| 2013-12-31 | 1.28x |
| 2013-09-30 | -23.88x |
| 2013-06-30 | -19.28x |
| 2013-03-31 | -23.28x |
| 2012-12-31 | -15.50x |
| 2012-09-30 | -14.30x |
| 2012-06-30 | -11.62x |
| 2012-03-31 | -11.02x |
| 2011-12-31 | -13.86x |
| 2011-09-30 | -14.34x |
| 2011-06-30 | -29.61x |
| 2011-03-31 | -2.60x |
| 2010-12-31 | -3.84x |
| 2010-09-30 | -13.22x |
| 2010-06-30 | -15.46x |
| 2010-03-31 | -14.07x |
| 2009-12-31 | -12.06x |
